Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

Kallikrein 3 and vitamin D receptor polymorphisms: potentials environmental risk factors for prostate cancer.

Hu J, Qiu Z, Zhang L, Cui F.

Diagn Pathol. 2014 Apr 22;9:84. doi: 10.1186/1746-1596-9-84.

PMID:
24755043
[PubMed - in process]
Free PMC Article
2.

Genome-wide association scan for variants associated with early-onset prostate cancer.

Lange EM, Johnson AM, Wang Y, Zuhlke KA, Lu Y, Ribado JV, Keele GR, Li J, Duan Q, Li G, Gao Z, Li Y, Xu J, Isaacs WB, Zheng S, Cooney KA.

PLoS One. 2014 Apr 16;9(4):e93436. doi: 10.1371/journal.pone.0093436. eCollection 2014.

PMID:
24740154
[PubMed - in process]
Free PMC Article
3.

The role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision making.

Van den Broeck T, Joniau S, Clinckemalie L, Helsen C, Prekovic S, Spans L, Tosco L, Van Poppel H, Claessens F.

Biomed Res Int. 2014;2014:627510. doi: 10.1155/2014/627510. Epub 2014 Feb 19.

PMID:
24701578
[PubMed - in process]
Free PMC Article
4.

Potential Urinary miRNA Biomarker Candidates for the Accurate Detection of Prostate Cancer among Benign Prostatic Hyperplasia Patients.

Haj-Ahmad TA, Abdalla MA, Haj-Ahmad Y.

J Cancer. 2014 Jan 29;5(3):182-91. doi: 10.7150/jca.6799. eCollection 2014.

PMID:
24563673
[PubMed]
Free PMC Article
5.

Comprehensive functional annotation of 77 prostate cancer risk loci.

Hazelett DJ, Rhie SK, Gaddis M, Yan C, Lakeland DL, Coetzee SG; Ellipse/GAME-ON consortium; Practical consortium, Henderson BE, Noushmehr H, Cozen W, Kote-Jarai Z, Eeles RA, Easton DF, Haiman CA, Lu W, Farnham PJ, Coetzee GA.

PLoS Genet. 2014 Jan 30;10(1):e1004102. doi: 10.1371/journal.pgen.1004102. eCollection 2014 Jan.

PMID:
24497837
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The genomic landscape of prostate cancer.

Spans L, Clinckemalie L, Helsen C, Vanderschueren D, Boonen S, Lerut E, Joniau S, Claessens F.

Int J Mol Sci. 2013 May 24;14(6):10822-51. doi: 10.3390/ijms140610822.

PMID:
23708091
[PubMed]
Free PMC Article
7.

Characterization of SNPs associated with prostate cancer in men of Ashkenazic descent from the set of GWAS identified SNPs: impact of cancer family history and cumulative SNP risk prediction.

Agalliu I, Wang Z, Wang T, Dunn A, Parikh H, Myers T, Burk RD, Amundadottir L.

PLoS One. 2013;8(4):e60083. doi: 10.1371/journal.pone.0060083. Epub 2013 Apr 3.

PMID:
23573233
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Prostate cancer risk-associated genetic markers and their potential clinical utility.

Xu J, Sun J, Zheng SL.

Asian J Androl. 2013 May;15(3):314-22. doi: 10.1038/aja.2013.42. Epub 2013 Apr 8.

PMID:
23564047
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Dab2IP GTPase activating protein regulates dendrite development and synapse number in cerebellum.

Qiao S, Kim SH, Heck D, Goldowitz D, LeDoux MS, Homayouni R.

PLoS One. 2013;8(1):e53635. doi: 10.1371/journal.pone.0053635. Epub 2013 Jan 9.

PMID:
23326475
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.

Amin Al Olama A, Kote-Jarai Z, Schumacher FR, Wiklund F, Berndt SI, Benlloch S, Giles GG, Severi G, Neal DE, Hamdy FC, Donovan JL, Hunter DJ, Henderson BE, Thun MJ, Gaziano M, Giovannucci EL, Siddiq A, Travis RC, Cox DG, Canzian F, Riboli E, Key TJ, Andriole G, Albanes D, Hayes RB, Schleutker J, Auvinen A, Tammela TL, Weischer M, Stanford JL, Ostrander EA, Cybulski C, Lubinski J, Thibodeau SN, Schaid DJ, Sorensen KD, Batra J, Clements JA, Chambers S, Aitken J, Gardiner RA, Maier C, Vogel W, Dörk T, Brenner H, Habuchi T, Ingles S, John EM, Dickinson JL, Cannon-Albright L, Teixeira MR, Kaneva R, Zhang HW, Lu YJ, Park JY, Cooney KA, Muir KR, Leongamornlert DA, Saunders E, Tymrakiewicz M, Mahmud N, Guy M, Govindasami K, O'Brien LT, Wilkinson RA, Hall AL, Sawyer EJ, Dadaev T, Morrison J, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As N, Woodhouse CJ, Thompson A, Dudderidge T, Ogden C, Cooper CS, Lophatonanon A, Southey MC, Hopper JL, English D, Virtamo J, Le Marchand L, Campa D, Kaaks R, Lindstrom S, Diver WR, Gapstur S, Yeager M, Cox A, Stern MC, Corral R, Aly M, Isaacs W, Adolfsson J, Xu J, Zheng SL, Wahlfors T, Taari K, Kujala P, Klarskov P, Nordestgaard BG, Røder MA, Frikke-Schmidt R, Bojesen SE, FitzGerald LM, Kolb S, Kwon EM, Karyadi DM, Orntoft TF, Borre M, Rinckleb A, Luedeke M, Herkommer K, Meyer A, Serth J, Marthick JR, Patterson B, Wokolorczyk D, Spurdle A, Lose F, McDonnell SK, Joshi AD, Shahabi A, Pinto P, Santos J, Ray A, Sellers TA, Lin HY, Stephenson RA, Teerlink C, Muller H, Rothenbacher D, Tsuchiya N, Narita S, Cao GW, Slavov C, Mitev V; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK ProtecT Study Collaborators; Australian Prostate Cancer Bioresource; PRACTICAL Consortium, Chanock S, Gronberg H, Haiman CA, Kraft P, Easton DF, Eeles RA.

Hum Mol Genet. 2013 Jan 15;22(2):408-15. doi: 10.1093/hmg/dds425. Epub 2012 Oct 12.

PMID:
23065704
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Evaluating genetic risk for prostate cancer among Japanese and Latinos.

Cheng I, Chen GK, Nakagawa H, He J, Wan P, Laurie CC, Shen J, Sheng X, Pooler LC, Crenshaw AT, Mirel DB, Takahashi A, Kubo M, Nakamura Y, Al Olama AA, Benlloch S, Donovan JL, Guy M, Hamdy FC, Kote-Jarai Z, Neal DE, Wilkens LR, Monroe KR, Stram DO, Muir K, Eeles RA, Easton DF, Kolonel LN, Henderson BE, Le Marchand L, Haiman CA.

Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):2048-58. doi: 10.1158/1055-9965.EPI-12-0598. Epub 2012 Aug 24.

PMID:
22923026
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

A comparison of Bayesian and frequentist approaches to incorporating external information for the prediction of prostate cancer risk.

Newcombe PJ, Reck BH, Sun J, Platek GT, Verzilli C, Kader AK, Kim ST, Hsu FC, Zhang Z, Zheng SL, Mooser VE, Condreay LD, Spraggs CF, Whittaker JC, Rittmaster RS, Xu J.

Genet Epidemiol. 2012 Jan;36(1):71-83. doi: 10.1002/gepi.21600.

PMID:
22890972
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Genetic and epigenetic changes in human prostate cancer.

Koochekpour S.

Iran Red Crescent Med J. 2011 Feb;13(2):80-98. Epub 2011 Feb 1.

PMID:
22737441
[PubMed]
Free PMC Article
14.

A novel germline mutation in HOXB13 is associated with prostate cancer risk in Chinese men.

Lin X, Qu L, Chen Z, Xu C, Ye D, Shao Q, Wang X, Qi J, Chen Z, Zhou F, Wang M, Wang Z, He D, Wu D, Gao X, Yuan J, Wang G, Xu Y, Wang G, Dong P, Jiao Y, Yang J, Ou-Yang J, Jiang H, Zhu Y, Ren S, Zhang Z, Yin C, Wu Q, Zheng Y, Turner AR, Tao S, Na R, Ding Q, Lu D, Shi R, Sun J, Liu F, Zheng SL, Mo Z, Sun Y, Xu J.

Prostate. 2013 Jan;73(2):169-75. doi: 10.1002/pros.22552. Epub 2012 Jun 21.

PMID:
22718278
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Confirmation of the HOXB13 G84E germline mutation in familial prostate cancer.

Breyer JP, Avritt TG, McReynolds KM, Dupont WD, Smith JR.

Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1348-53. doi: 10.1158/1055-9965.EPI-12-0495. Epub 2012 Jun 19.

PMID:
22714738
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial.

Kader AK, Sun J, Reck BH, Newcombe PJ, Kim ST, Hsu FC, D'Agostino RB Jr, Tao S, Zhang Z, Turner AR, Platek GT, Spraggs CF, Whittaker JC, Lane BR, Isaacs WB, Meyers DA, Bleecker ER, Torti FM, Trent JM, McConnell JD, Zheng SL, Condreay LD, Rittmaster RS, Xu J.

Eur Urol. 2012 Dec;62(6):953-61. doi: 10.1016/j.eururo.2012.05.006. Epub 2012 May 12.

PMID:
22652152
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Genetic polymorphism and prostate cancer aggressiveness: a case-only study of 1,536 GWAS and candidate SNPs in African-Americans and European-Americans.

Bensen JT, Xu Z, Smith GJ, Mohler JL, Fontham ET, Taylor JA.

Prostate. 2013 Jan;73(1):11-22. doi: 10.1002/pros.22532. Epub 2012 May 1.

PMID:
22549899
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Inherited susceptibility for aggressive prostate cancer.

Isaacs WB.

Asian J Androl. 2012 May;14(3):415-8. doi: 10.1038/aja.2011.146. Epub 2012 Apr 30. Review.

PMID:
22543676
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Gene variants in the angiogenesis pathway and prostate cancer.

Amankwah EK, Sellers TA, Park JY.

Carcinogenesis. 2012 Jul;33(7):1259-69. doi: 10.1093/carcin/bgs150. Epub 2012 Apr 20. Review.

PMID:
22523086
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Using graded response model for the prediction of prostate cancer risk.

Chen SH, Ip EH, Xu J, Sun J, Hsu FC.

Hum Genet. 2012 Aug;131(8):1327-36. doi: 10.1007/s00439-012-1160-8. Epub 2012 Mar 30.

PMID:
22461065
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk